News J&J's Tremfya gets funding in Germany and UK Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany.
News Scotland's NHS to fund Ipsen cancer diarrhoea drug Decision welcomed as step forward for patients
News Pfizer will have to cut price of AML drug Mylotarg after NIC... NICE blocks access to 65% of patients on cost grounds
News Novartis/Amgen's migraine drug hits market at lower than exp... The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and at a lower than expected list price of $6,900.
Partner Content Partner Content Neil Levinson joins ACCRETIO as Strategy Director Neil Levinson joins ACCRETIO as Strategy Director
Partner Content Partner Content Jayne Hurrell joins OPEN Access Consulting as Director of Gl... Jayne Hurrell joins OPEN Access Consulting as Director
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
